Fig. 3: Construction of CD4 T cell risk score model. | Cell Death & Disease

Fig. 3: Construction of CD4 T cell risk score model.

From: A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCC

Fig. 3

A CD4 T cell unifactor Cox analysis of forest map. B, C LASSO regression analysis diagram. D KM survival curves of high-risk group and low-risk group. E Survival map of ESCC patients in TCGA. F Risk score map of ESCC patients in TCGA. G Heat maps of expression levels of four T cell marker genes in high-risk and low-risk groups. H GSEA pathway enrichment analysis diagram. I 1/3/5 year ROC curve of the risk scoring model. J PCA diagram of risk assessment model. K, L IHC analysis of the paraffin-embedded ESCC tissues using a HSPH1 antibody and the corresponding quantification. P < 0.05. *P < 0.05, **P < 0.01; ***P < 0.001.

Back to article page